UBS’s Artivion AORT Stock Holding History

UBS’s Portfolio AORT Stock Details AORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$15K	Buy	+1,500	New	+$14.8K	﹤0.01%	8336
2013 Q3	–	Sell	-500	Closed	-$3K	–	10324
2013 Q2	$3K	Buy	+500	New	+$3.05K	﹤0.01%	9574

Other funds holding AORT

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Killen Group Berwyn, Pennsylvania $866M AUM 0.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

UBS's AORT Position: Q3 2014 in Review

UBS reduced its Artivion (AORT) stake by 4.3% in Q3 2014, selling an estimated $9.25K and leaving 20,761 shares worth $205K. The position accounts for ﹤0.01% of the portfolio, ranked #5155.

UBS first reported a position in AORT in Q2 2013 and has held it in 6 quarters since. 113 funds tracked by Wall St. Rank hold AORT as of Q3 2014.

UBS held 20,761 shares of Artivion worth $205K as of Q3 2014.
UBS sold 941 Artivion shares in Q3 2014, an estimated $9.25K.
Artivion made up ﹤0.01% of UBS's portfolio in Q3 2014, its #5155 holding.
UBS first reported a position in Artivion in Q2 2013 and has held it in 6 quarters since.
113 funds tracked by Wall St. Rank held Artivion as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.